Dermatology Pipeline Updates: Plaque Psoriasis, Atopic Dermatitis and More
The current dermatology pipeline includes a wide range of medication classes, from Janus kinase (JAK) inhibitors to tumor necrosis factor inhibitors, to phototherapeutics. At the 2023 American Society of Health-System Pharmacists (ASHP) Summer Meetings and Exhibition,1 Courtney Queen, PharmD, CSP, of the University of Kentucky Specialty Pharmacy and Infusion Services in Lexington, Kentucky, shared a quick snapshot of some of that pipeline. Although only 4 conditions were covered—chosen due to the high number of agents in the pipeline—Queen noted that “there are so many more [drugs] we could talk about.”
Reference
1. Rim M, Queen C, Huffmyer M. Specialty pharmacy pipeline updates II: Emerging therapies for complex conditions. Presented at: American Society of Health-System Pharmacists Summer Meetings and Exhibition; June 10-14, 2023; Baltimore, MD.
IRA Drug Price Negotiations to Have Far-Reaching Consequences on Health Care System | Asembia 2025
May 1st 2025The Inflation Reduction Act's drug price negotiations could lead to reimbursement complexities, potential pharmacy closures, and reduced patient access to medications, particularly specialty drugs.
